Session » Miscellaneous Rheumatic & Inflammatory Diseases Poster II: Clinical Features & Diagnostics (1083–1117)

Date: Monday, November 8, 2021

Time: 8:30AM-10:30AM

Meeting: ACR Convergence 2021

8:30AM-10:30AM: Abstract Number: 1092

Altered Metabolic Pathways in Synovial Fibroblasts of Individuals at Risk of Developing Rheumatoid Arthritis

8:30AM-10:30AM: Abstract Number: 1101

Atypical Pulmonary Radiographic Findings May Help Identify Patients with Usual Interstitial Pneumonia and Autoimmune Features

8:30AM-10:30AM: Abstract Number: 1093

Cardiovascular and Lipid Biomarker Distributions in Inflammatory Arthritis

8:30AM-10:30AM: Abstract Number: 1099

Characteristics and Outcomes of Myocardial Infarction in Patients with Rheumatoid Arthritis, Systemic Lupus Erythematosus, Systemic Sclerosis, Gout and Osteoarthritis Patients Using the National Inpatient Sample Database from 2002-2018

8:30AM-10:30AM: Abstract Number: 1107

Clinical and Genetic Features of Chinese Adult Patients with Chronic Non-bacterial Osteomyelitis: A Single Center Report

8:30AM-10:30AM: Abstract Number: 1089

Clinical Associations of Anti-Ro52 Antibodies in Patients with Systemic Autoimmune Rheumatic Diseases

8:30AM-10:30AM: Abstract Number: 1102

Comorbidities and Causes of Hospitalizations in a Cohort of IgG4-Related Disease Patients from a Single Center

8:30AM-10:30AM: Abstract Number: 1109

Comparison of Diagnostic Criteria in Behçet’s Disease and Sensitivity in Diagnosing Severe Manifestations

8:30AM-10:30AM: Abstract Number: 1090

Contribution of Scleroderma/Myositis-Related Antibodies Detected by Immunoblot to the Diagnosis of Systemic Autoimmune Rheumatic Diseases in 134 Patients from a Single Referral Center

8:30AM-10:30AM: Abstract Number: 1085

COVID 19 Infection in Patients with Rheumatic Immune-mediated Diseases in a Single University Hospital: Matched Case-control Study

8:30AM-10:30AM: Abstract Number: 1084

COVID-19 Among Patients with Inflammatory Arthropathies Participating in the RHUMADATA Clinical Database and Registry

8:30AM-10:30AM: Abstract Number: 1110

Cryopyrin-associated Periodic Syndromes: GOSH and National Amyloidosis Centre Experience

8:30AM-10:30AM: Abstract Number: 1096

CSF-specific CD8 T Cell Clonal Expansion in Neurosarcoidosis

8:30AM-10:30AM: Abstract Number: 1105

Discovering Variants in Suspected Monogenic Systemic Inflammatory Disease: An Adult Case Series

8:30AM-10:30AM: Abstract Number: 1103

Disease Associations with Very High Serum IgG4 Concentrations: A Retrospective Multi-Center Study

8:30AM-10:30AM: Abstract Number: 1116

Disease Characteristics of Steroid-Induced Spinal Epidural Lipomatosis: A Systematic Review

8:30AM-10:30AM: Abstract Number: 1098

Does Cancer Masquerade as Sarcoidosis?

8:30AM-10:30AM: Abstract Number: 1094

Extremely Elevated Erythrocyte Sedimentation Rate Revisited in Rheumatic Diseases: Flare-Up or Infection? Single Centre Retrospective Analysis

8:30AM-10:30AM: Abstract Number: 1097

Gastrointestinal Malignancies in Sarcoidosis: A Nationwide Analysis

8:30AM-10:30AM: Abstract Number: 1095

Improved Arthrocentesis and Fluid Yield of the Non-Effusive Knee Using Pneumatic Compression

8:30AM-10:30AM: Abstract Number: 1086

Lack of Effect of SARS-CoV-2 Vaccination on Cell Bound Complement Activation Products (CB-CAPs), Multianalyte Assay Panel (MAP) with Algorithm, and Inflammatory Biomarkers

8:30AM-10:30AM: Abstract Number: 1108

More Frequent, Earlier Hip Involvement and Poor Outcome in Spondyloarthritis Associated with Familial Mediterranean Fever

8:30AM-10:30AM: Abstract Number: 1117

Ocular Scleral Pathology: Clinical Features and Systemic Treatment in 175 Patients from a Single University Center

8:30AM-10:30AM: Abstract Number: 1083

Outcomes of COVID-19 Illness in Systemic Autoinflammatory Diseases and Changes in Flares During the COVID-19 Pandemic: An International Survey

8:30AM-10:30AM: Abstract Number: 1114

Pachymeningitis: The Mayo Clinic Experience

8:30AM-10:30AM: Abstract Number: 1104

Pathogenic UBA1 Variants in Japanese Patients with Relapsing Polychondritis

8:30AM-10:30AM: Abstract Number: 1106

Phenotypes and Genotypes of NLRP3-AID in Chinese Adult Patients

8:30AM-10:30AM: Abstract Number: 1100

Pulmonary Arterial Hypertension in Adult-Onset Still’s Disease: A Case Series of 13 Patients

8:30AM-10:30AM: Abstract Number: 1091

Serum Metabolomic Profiling Identifies Potential Biomarkers in Arthritis in the Elderly

8:30AM-10:30AM: Abstract Number: 1088

The Association Between Anti-Type Ⅱ Collagen Antibodies at the Time of Diagnosis and Recurrence in Relapsing Polychondritis

8:30AM-10:30AM: Abstract Number: 1087

The Humoral Immunity of mRNA-Based SARS-CoV2 Vaccine in Autoimmune Rheumatic Disease Patients Receiving Immunomodulators

8:30AM-10:30AM: Abstract Number: 1112

Transient Elastography (Fibroscan) as a Non-Invasive Method for Detecting Amyloid Deposition in Transplanted Kidneys in Patients with AA Amyloidosis

8:30AM-10:30AM: Abstract Number: 1111

Transient Elastography (fibroscan); As a New Non-invasive Diagnostic Method for Detecting Hepatic Involvement of Amyloidosis

8:30AM-10:30AM: Abstract Number: 1115

Uveitis and Inflammatory Bowel Disease: Study of 1449 Patients from a Single University Center

8:30AM-10:30AM: Abstract Number: 1113

Validation of the 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease in a Latin American Cohort

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].